Learn how to turn basic discoveries from the laboratories to drugs, medical devices or clinical processes for use in the patient-care setting through our Master of Science in Clinical Translation Management program.
The MCTM program will help students with market entry and funding strategies to move a project forward while facilitating technologies that show significant promise in navigating the translational process, allowing new treatments and cures to reach patients.
Students will learn how to identify the qualities that make a biotechnology product or company likely to succeed in the endeavor to commercialize their product. From there, they can find ways to navigate and address any potential scientific, legal, financial, and management issues that might arise at any stage of commercialization.
This accelerated one-year program is cohort-based that admits once a year during the Summer II semester. Courses are asynchronous and online, with in-person residencies and networking opportunities. Options are also available for a MCTM/MBA dual degree or Certified Quality Science Professional (CQSP) certification.